Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 26, Issue 10, Pages 1163-1173
Publisher
Informa UK Limited
Online
2017-08-24
DOI
10.1080/13543784.2017.1371133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases
- (2017) A Mascolo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
- (2017) Juraj Culman et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease
- (2016) Qiang Tong et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- To Sensitize or Not to Sensitize
- (2016) Amy C. Arnold HYPERTENSION
- Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease
- (2016) Natalia Pessoa Rocha et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Mitochondrial-dependent mechanisms are involved in angiotensin II-induced apoptosis in dopaminergic neurons
- (2016) Z. Ou et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Evolving basic, pathological and clinical concepts in PD
- (2016) Lorraine V. Kalia et al. Nature Reviews Neurology
- Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration
- (2016) Rita Valenzuela et al. Cell Death & Disease
- Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum
- (2015) E. Martínez-Pinilla et al. BIOCHEMICAL PHARMACOLOGY
- Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions
- (2015) Jaspreet Kalra et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Activation of Autophagy Contributes to the Angiotensin II-Triggered Apoptosis in a Dopaminergic Neuronal Cell Line
- (2015) Qing Gao et al. MOLECULAR NEUROBIOLOGY
- Novel RAAS agonists and antagonists: clinical applications and controversies
- (2015) Cesar A. Romero et al. Nature Reviews Endocrinology
- Angiotensin AT2 receptor stimulation inhibits activation of NADPH oxidase and ameliorates oxidative stress in rotenone model of Parkinson's disease in CATH.a cells
- (2015) Jie Lu et al. NEUROTOXICOLOGY AND TERATOLOGY
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
- (2015) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- Loss of angiotensin II receptor expression in dopamine neurons in Parkinson’s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation
- (2015) W Michael Zawada et al. Acta Neuropathologica Communications
- Neuroprotective Effects of Angiotensin Receptor Blockers
- (2014) Sonia Villapol et al. AMERICAN JOURNAL OF HYPERTENSION
- Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β
- (2014) Ana Muñoz et al. EXPERIMENTAL NEUROLOGY
- Aging-related dysregulation of dopamine and angiotensin receptor interaction
- (2014) Begoña Villar-Cheda et al. NEUROBIOLOGY OF AGING
- Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
- (2014) Yen-Chieh Lee et al. PLoS One
- The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism
- (2013) Patricia K. Sonsalla et al. EXPERIMENTAL NEUROLOGY
- Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin
- (2013) Ana Borrajo et al. GLIA
- The angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson’s disease
- (2013) Gang Su et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Dopamine-Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease
- (2013) Jose L. Labandeira-Garcia et al. MOVEMENT DISORDERS
- Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice
- (2013) Sekar Sathiya et al. NEUROPHARMACOLOGY
- Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA
- (2013) Antonio Dominguez-Meijide et al. NEUROPHARMACOLOGY
- Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease
- (2013) Liang Wu et al. NEUROSCIENCE LETTERS
- Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression
- (2013) M-L Ancelin et al. Translational Psychiatry
- Classic and New Animal Models of Parkinson's Disease
- (2012) Javier Blesa et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease
- (2012) Pablo Garrido-Gil et al. Journal of Neuroinflammation
- Trial designs used to study neuroprotective therapy in Parkinson's disease
- (2012) Anthony E. Lang et al. MOVEMENT DISORDERS
- Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
- (2012) Begoña Villar-Cheda et al. NEUROBIOLOGY OF DISEASE
- Factors related to orthostatic hypotension in Parkinson's disease
- (2012) Santiago Perez-Lloret et al. PARKINSONISM & RELATED DISORDERS
- The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death
- (2011) Birgit Mertens et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Projected numbers of people with movement disorders in the years 2030 and 2050
- (2011) Jan-Philipp Bach et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson’s disease
- (2010) Begoña Villar-Cheda et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Location of Prorenin Receptors in Primate Substantia Nigra: Effects on Dopaminergic Cell Death
- (2010) Rita Valenzuela et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Neuronal Apoptosis Induced by Endoplasmic Reticulum Stress Is Regulated by ATF4-CHOP-Mediated Induction of the Bcl-2 Homology 3-Only Member PUMA
- (2010) Z. Galehdar et al. JOURNAL OF NEUROSCIENCE
- Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum
- (2010) Birgit Mertens et al. NEUROPHARMACOLOGY
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension
- (2009) Kaycee M. Sink et al. ARCHIVES OF INTERNAL MEDICINE
- PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson’s disease
- (2009) Nicoletta Schintu et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease
- (2009) Belen Joglar et al. JOURNAL OF NEUROCHEMISTRY
- The role of the central renin-angiotensin system in Parkinson’s disease
- (2009) Birgit Mertens et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- USE OF ANTIHYPERTENSIVES AND THE RISK OF PARKINSON DISEASE
- (2009) A. Ascherio et al. NEUROLOGY
- Ang II and Ang IV: Unraveling the Mechanism of Action on Synaptic Plasticity, Memory, and Epilepsy
- (2008) Dimitri De Bundel et al. CNS Neuroscience & Therapeutics
- Physiology of the normal and dopamine-depleted basal ganglia: Insights into levodopa pharmacotherapy
- (2008) Anthony A. Grace MOVEMENT DISORDERS
- The history of dopamine and levodopa in the treatment of Parkinson's disease
- (2008) Stanley Fahn MOVEMENT DISORDERS
- Use of antihypertensives and the risk of Parkinson disease
- (2008) C. Becker et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search